Parameter | T/B1 | P | T/B2 | P |
Irrespective of BRAF | ||||
TERT+ | 2.04 ± 0.82 | <0.001 | 1.80 ± 0.97 | <0.001 |
TERT− | 18.54 ± 21.84 | 12.30 ± 12.01 | ||
Irrespective of TERT | ||||
BRAF+ | 6.29 ± 8.97 | 0.012 | 5.17 ± 6.86 | 0.011 |
BRAF− | 23.45 ± 24.92 | 14.76 ± 13.19 | ||
BRAF+ | ||||
BRAF+TERT+ | 1.87 ± 0.72 | 0.049 | 1.61 ± 0.87 | 0.038 |
BRAF+TERT− | 9.1 ± 10.69 | 7.43 ± 8.07 | ||
BRAF− | ||||
BRAF-TERT+ | 3.22* | 0.420 | 3.13 | 0.380 |
BRAF−TERT− | 24.64 ± 25.15 | 15.44 ± 13.26 |
↵* T/B ratio was available for only one patient with TERT mutation alone.
T/B1 = ratio after first radioiodine therapy, with thyroid remnant; T/B2 = ratio after subsequent radioiodine therapy, without thyroid remnant.